Radiothérapie avec modulation d’intensité et radiothérapie stéréotaxique des tumeurs ORL : médecine fondée sur les preuves

HAS, 2009 Institut national du cancer (Inca), 2009 Giraud, 2013, RCMI et voies aérodigestives supérieures : le fractionnement différentiel a-t-il un intérêt ?, Cancer Radiother, 17, 502, 10.1016/j.canrad.2013.05.009 Pignon, 2009, Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients, Radiother Oncol, 92, 4, 10.1016/j.radonc.2009.04.014 Jeremic, 2004, Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck, J Clin Oncol, 22, 3540, 10.1200/JCO.2004.10.076 Cooper, 2004, Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck, N Engl J Med, 350, 1937, 10.1056/NEJMoa032646 Bonner, 2006, Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck, N Engl J Med, 354, 567, 10.1056/NEJMoa053422 Bonner, 2010, Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival, Lancet Oncol, 11, 21, 10.1016/S1470-2045(09)70311-0 Bourhis, 2006, Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis, Lancet, 368, 843, 10.1016/S0140-6736(06)69121-6 Blanchard, 2014, Meta-analysis of radiotherapy in head and neck cancers: exploratory analysis according to patient characteristics, Radiother Oncol, 111, 32, 10.1016/S0167-8140(15)30162-6 Bentzen, 2008, Randomized controlled trials in health technology assessment: overkill or overdue?, Radiother Oncol, 86, 142, 10.1016/j.radonc.2008.01.012 Hong, 2005, The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy, Int J Radiat Oncol Biol Phys, 61, 779, 10.1016/j.ijrobp.2004.07.696 Ang, 1990, Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx, Int J Radiat Oncol Biol Phys, 19, 1339, 10.1016/0360-3016(90)90341-G Butler, 1999, Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy, Int J Radiat Oncol Biol Phys, 45, 21, 10.1016/S0360-3016(99)00101-7 Ghoshal, 2008, Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck – a phase III trial from a single institution in India, Clin Oncol R Coll Radiol G B, 20, 212, 10.1016/j.clon.2008.01.011 Kam, 2007, Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients, J Clin Oncol, 25, 4873, 10.1200/JCO.2007.11.5501 Nutting, 2011, Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial, Lancet Oncol, 12, 127, 10.1016/S1470-2045(10)70290-4 Gupta, 2012, Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial, Radiother Oncol, 104, 343, 10.1016/j.radonc.2012.07.001 Peng, 2012, A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma, Radiother Oncol, 104, 286, 10.1016/j.radonc.2012.08.013 Gulliford, 2012, Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial, Radiother Oncol, 104, 205, 10.1016/j.radonc.2012.07.005 Marta, 2014, Intensity-modulated radiation therapy for head and neck cancer: Systematic review and meta-analysis, Radiother Oncol, 110, 9, 10.1016/j.radonc.2013.11.010 Eisbruch, 2010, Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22), Int J Radiat Oncol Biol Phys, 76, 1333, 10.1016/j.ijrobp.2009.04.011 Lohia, 2014, A Comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer, JAMA Otolaryngol Head Neck Surg, 140, 331, 10.1001/jamaoto.2013.6777 Studer, 2006, IMRT in hypopharyngeal tumors, Strahlenther Onkol, 182, 331, 10.1007/s00066-006-1556-2 Studer, 2010, Surviving hypopharynx-larynx carcinoma in the era of IMRT, Int J Radiat Oncol Biol Phys, 77, 1391, 10.1016/j.ijrobp.2009.07.005 Adams, 2001, Potential role of intensity-modulated radiotherapy in the treatment of tumors of the maxillary sinus, Int J Radiat Oncol Biol Phys, 51, 579, 10.1016/S0360-3016(01)01655-8 Daly, 2007, Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses, Int J Radiat Oncol Biol Phys, 67, 151, 10.1016/j.ijrobp.2006.07.1389 Dirix, 2010, Intensity-modulated radiotherapy for sinonasal cancer: improved outcome compared to conventional radiotherapy, Int J Radiat Oncol Biol Phys, 78, 998, 10.1016/j.ijrobp.2009.09.067 Toledano, 2012, Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004–03, Radiother Oncol, 103, 57, 10.1016/j.radonc.2011.12.010 Pow, 2006, Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial, Int J Radiat Oncol Biol Phys, 66, 981, 10.1016/j.ijrobp.2006.06.013 Lee, 2009, Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225, J Clin Oncol, 27, 3684, 10.1200/JCO.2008.19.9109 Lai, 2011, How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?, Int J Radiat Oncol Biol Phys, 80, 661, 10.1016/j.ijrobp.2010.03.024 Lapeyre, 2004, Radiothérapie conformationnelle avec modulation d’intensité des cancers des voies aérodigestives supérieures avec irradiation bilatérale du cou : résultats préliminaires, Cancer Radiother, 8, 134, 10.1016/j.canrad.2004.03.001 Feng, 2007, Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures, Int J Radiat Oncol Biol Phys, 68, 1289, 10.1016/j.ijrobp.2007.02.049 Tsai, 2013, Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer, Int J Radiat Oncol Biol Phys, 85, 415, 10.1016/j.ijrobp.2012.05.032 Chi, 2013, Intensity modulated radiotherapy for sinonasal malignancies with a focus on optic pathway preservation, J Hematol Oncol, 6, 4, 10.1186/1756-8722-6-4 Bhandare, 2010, Radiation therapy and hearing loss, Int J Radiat Oncol Biol Phys, 76, S50, 10.1016/j.ijrobp.2009.04.096 Petsuksiri, 2011, Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients, Radiat Oncol, 6, 19, 10.1186/1748-717X-6-19 Hoebers, 2011, Reirradiation for head-and-neck cancer: delicate balance between effectiveness and toxicity, Int J Radiat Oncol Biol Phys, 81, e111, 10.1016/j.ijrobp.2011.01.004 Janot, 2008, Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma, J Clin Oncol, 26, 5518, 10.1200/JCO.2007.15.0102 Rwigema J-CM, 2011, The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy, Am J Clin Oncol, 34, 372, 10.1097/COC.0b013e3181e84dc0 Vargo, 2012, Prospective evaluation of patient-reported quality-of-life outcomes following SBRT±cetuximab for locally-recurrent, previously-irradiated head and neck cancer, Radiother Oncol, 104, 91, 10.1016/j.radonc.2012.04.020 Vargo, 2014, Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer, Laryngoscope, 124, 1579, 10.1002/lary.24441 Lartigau, 2013, Multi-institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer, Radiother Oncol, 109, 281, 10.1016/j.radonc.2013.08.012 Kawaguchi, 2010, Stereotactic radiosurgery may contribute to overall survival for patients with recurrent head and neck carcinoma, Radiat Oncol, 5, 51, 10.1186/1748-717X-5-51 Cengiz, 2011, Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors, Int J Radiat Oncol Biol Phys, 81, 104, 10.1016/j.ijrobp.2010.04.027 Chua, 2009, Comparison of single versus fractionated dose of stereotactic radiotherapy for salvaging local failures of nasopharyngeal carcinoma: a matched-cohort analysis, Head Neck Oncol, 1, 13, 10.1186/1758-3284-1-13 Al-Mamgani, 2012, Stereotactic body radiotherapy: a promising treatment option for the boost of oropharyngeal cancers not suitable for brachytherapy: a single-institutional experience, Int J Radiat Oncol Biol Phys, 82, 1494, 10.1016/j.ijrobp.2011.05.019 Al-Mamgani, 2013, Brachytherapy or stereotactic body radiotherapy boost for early-stage oropharyngeal cancer: comparable outcomes of two different approaches, Oral Oncol, 49, 1018, 10.1016/j.oraloncology.2013.07.007 Levendag, 2002, High-dose, high-precision treatment options for boosting cancer of the nasopharynx, Radiother Oncol, 63, 67, 10.1016/S0167-8140(02)00008-7